- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00947648
Outpatient Neutropenic Diet Study
Are Neutropenic Diets Beneficial to Improve Outcome?
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This study is comparing two different diets. The cooked group will be allowed to eat only cooked food and cooked fruits or vegetables. The raw group will be able to eat cooked food and the addition of fresh fruits and vegetables. Patients will be monitored for infection in both groups. There are still certain foods that you are restricted from eating while receiving chemotherapy and you will be given a list of these restrictions.
Study Groups:
If you agree to take part in this study, you will be randomly assigned (as in the flip of a coin) to 1 of 2 groups.
Group 1: Raw group: You will be asked to eat at least 1 raw fruit or vegetable every day you are on study.
Group 2: Cooked group: You will eat only cooked foods while on study. The study doctor will give you a list of the foods that you are allowed to eat.
Your medical chart will be monitored while you are on study to check how often you need antibiotics to treat fever. or if you have an infection.
Diet Questionnaire:
You will be asked to fill out a diet questionnaire every week. The questionnaire will have 5 questions about the foods you have been eating. If you have been released from the hospital, you can return the questionnaire during your scheduled hospital visits,which typically take place 3 times per week. You will have no additional visits during this study. The questionnaire should take about 1-2 minutes each time.
Length of Study:
You will be taken off study if your white blood cell count returns to normal. If your white blood cell counts do not return to normal, the maximum time that you may be on study is 6 weeks.
This is an investigational study. There has not been enough research to prove if raw fruits and vegetables can increase your risk of infection. Many hospitals allow neutropenic patients to eat raw fruits and vegetables and other hospitals restrict fresh fruits and vegetables but, this has not been adequately investigated.
Up to 128 patients will take part in this study. All will be enrolled at M. D. Anderson.
Studietyp
Inskrivning (Faktisk)
Fas
- Fas 2
Kontakter och platser
Studieorter
-
-
Texas
-
Houston, Texas, Förenta staterna, 77030
- U.T. M.D. Anderson Cancer Center
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Newly diagnosed patients with acute myelogenous leukemia (AML), acute lymphocytic leukemia ( ALL), or myelodysplastic syndrome (MDS) receiving induction chemotherapy or AML, ALL or MDS patients who are in remission receiving consolidation chemotherapy.
- Patients who will be receiving myelosuppressive chemotherapy for their disease.
- Patients who will be able to stay in the Houston area for at least 4 weeks.
- Patients who can speak either English or Spanish.
Exclusion Criteria:
- Patients who present with an active infection such as pneumonia, bacteremia, urine, c. difficile or cellulitis infection.
- Patients who are unable to understand the diet questionnaire which will be written in either English or Spanish.
- Patients who are admitted to the protective environment.
- Patients who are younger than age 18 will not be entered in the study.
- Pregnant patients.
Studieplan
Hur är studien utformad?
Designdetaljer
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Övrig: "Raw" Group
Participants will eat cooked food and the addition of raw fruits and vegetables.
|
Diet containing fresh fruits and vegetables in addition to cooked food.
|
|
Övrig: "Cooked" Group
Participants will eat only cooked foods.
|
Diet containing only cooked foods.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Number of Bactermia in Each Participant Group
Tidsram: 6 weeks
|
Participants evaluated for presence of bacteremia (gram positive, gram negative, and or candidemia).
Participants also evaluated for neutropenic fever requiring administration of antibiotics even if the participant does not have a positive blood culture on a weekly basis.
At least 2 positive blood cultures are needed for coagulase-negative staphylococci (CoNS) to be considered bacteremia.
|
6 weeks
|
|
Infection Rate
Tidsram: 6 weeks
|
Episodes of neutropenic fevers requiring IV antibiotics and or hospitalization because many times patients have an infection but there is no positive blood cultures.
Evaluation of bacteremia will be done by the two nurse investigators via a data questionnaire weekly, see Appendix E. Patients will require at least 2 positive blood cultures for coag neg staph to be considered bacteremia and if there are any other questionable organisms that could be a contaminant, an infectious disease expert is one of the co-investigators and this person will be consulted if this positive blood culture is considered an infection.
If the patient has a fever requiring antibiotics with this positive blood culture, then this will also be considered as to whether this is a true infection.
|
6 weeks
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Alison E Gardner, PhD, M.D. Anderson Cancer Center
Publikationer och användbara länkar
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2008-0369
- NCI-2009-01509 (Registeridentifierare: NCI CTRP)
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .